182 related articles for article (PubMed ID: 27216059)
21.
Nefertiti ASG; Batista MM; Da Silva PB; Batista DGJ; Da Silva CF; Peres RB; Torres-Santos EC; Cunha-Junior EF; Holt E; Boykin DW; Brun R; Wenzler T; Soeiro MNC
Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29203485
[TBL] [Abstract][Full Text] [Related]
22. Clomipramine and Benznidazole Act Synergistically and Ameliorate the Outcome of Experimental Chagas Disease.
García MC; Ponce NE; Sanmarco LM; Manzo RH; Jimenez-Kairuz AF; Aoki MP
Antimicrob Agents Chemother; 2016 Jun; 60(6):3700-8. PubMed ID: 27067322
[TBL] [Abstract][Full Text] [Related]
23. Arylimidamide DB766, a potential chemotherapeutic candidate for Chagas' disease treatment.
Batista Dda G; Batista MM; de Oliveira GM; do Amaral PB; Lannes-Vieira J; Britto CC; Junqueira A; Lima MM; Romanha AJ; Sales Junior PA; Stephens CE; Boykin DW; Soeiro Mde N
Antimicrob Agents Chemother; 2010 Jul; 54(7):2940-52. PubMed ID: 20457822
[TBL] [Abstract][Full Text] [Related]
24. Concomitant Benznidazole and Suramin Chemotherapy in Mice Infected with a Virulent Strain of Trypanosoma cruzi.
Santos EC; Novaes RD; Cupertino MC; Bastos DS; Klein RC; Silva EA; Fietto JL; Talvani A; Bahia MT; Oliveira LL
Antimicrob Agents Chemother; 2015 Oct; 59(10):5999-6006. PubMed ID: 26169419
[TBL] [Abstract][Full Text] [Related]
25. Structural design, synthesis and pharmacological evaluation of thiazoles against Trypanosoma cruzi.
de Oliveira Filho GB; Cardoso MVO; Espíndola JWP; Oliveira E Silva DA; Ferreira RS; Coelho PL; Anjos PSD; Santos ES; Meira CS; Moreira DRM; Soares MBP; Leite ACL
Eur J Med Chem; 2017 Dec; 141():346-361. PubMed ID: 29031078
[TBL] [Abstract][Full Text] [Related]
26. In vitro trypanocidal activity of DB745B and other novel arylimidamides against Trypanosoma cruzi.
Da Silva CF; Junqueira A; Lima MM; Romanha AJ; Sales Junior PA; Stephens CE; Som P; Boykin DW; Soeiro Mde N
J Antimicrob Chemother; 2011 Jun; 66(6):1295-7. PubMed ID: 21478242
[TBL] [Abstract][Full Text] [Related]
27. In vitro activity of 1,3-bisaryloxypropanamines against Trypanosoma cruzi-infected L929 cultures.
Lavorato SN; Sales Júnior PA; Murta SM; Romanha AJ; Alves RJ
Mem Inst Oswaldo Cruz; 2015 Jun; 110(4):566-8. PubMed ID: 26061148
[TBL] [Abstract][Full Text] [Related]
28. Designing and exploring active N'-[(5-nitrofuran-2-yl) methylene] substituted hydrazides against three Trypanosoma cruzi strains more prevalent in Chagas disease patients.
Palace-Berl F; Pasqualoto KF; Jorge SD; Zingales B; Zorzi RR; Silva MN; Ferreira AK; de Azevedo RA; Teixeira SF; Tavares LC
Eur J Med Chem; 2015; 96():330-9. PubMed ID: 25899337
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and trypanocidal activity of a library of 4-substituted 2-(1H-pyrrolo[3,2-c]pyridin-2-yl)propan-2-ols.
Balfour MN; Franco CH; Moraes CB; Freitas-Junior LH; Stefani HA
Eur J Med Chem; 2017 Mar; 128():202-212. PubMed ID: 28189084
[TBL] [Abstract][Full Text] [Related]
30. Novel Gallate Triphenylphosphonium Derivatives with Potent Antichagasic Activity.
Cortes LA; Castro L; Pesce B; Maya JD; Ferreira J; Castro-Castillo V; Parra E; Jara JA; López-Muñoz R
PLoS One; 2015; 10(8):e0136852. PubMed ID: 26317199
[TBL] [Abstract][Full Text] [Related]
31. Identification of three classes of heteroaromatic compounds with activity against intracellular Trypanosoma cruzi by chemical library screening.
Bettiol E; Samanovic M; Murkin AS; Raper J; Buckner F; Rodriguez A
PLoS Negl Trop Dis; 2009; 3(2):e384. PubMed ID: 19238193
[TBL] [Abstract][Full Text] [Related]
32. Activity of pyridyl-pyrazolone derivatives against Trypanosoma cruzi.
Batista DDGJ; de Almeida Fiuza LF; Klupsch F; da Costa KN; Batista MM; da Conceição K; Bouafia H; Vergoten G; Millet R; Thuru X; Bailly C; Soeiro MNC
Exp Parasitol; 2024 Jul; 262():108787. PubMed ID: 38759776
[TBL] [Abstract][Full Text] [Related]
33. In vitro and in vivo antiparasitic activity of Physalis angulata L. concentrated ethanolic extract against Trypanosoma cruzi.
Meira CS; Guimarães ET; Dos Santos JA; Moreira DR; Nogueira RC; Tomassini TC; Ribeiro IM; de Souza CV; Ribeiro Dos Santos R; Soares MB
Phytomedicine; 2015 Oct; 22(11):969-74. PubMed ID: 26407938
[TBL] [Abstract][Full Text] [Related]
34. Synthesis and 2D-QSAR studies of neolignan-based diaryl-tetrahydrofuran and -furan analogues with remarkable activity against Trypanosoma cruzi and assessment of the trypanothione reductase activity.
Hartmann AP; de Carvalho MR; Bernardes LSC; Moraes MH; de Melo EB; Lopes CD; Steindel M; da Silva JS; Carvalho I
Eur J Med Chem; 2017 Nov; 140():187-199. PubMed ID: 28926763
[TBL] [Abstract][Full Text] [Related]
35. Efficacy of Novel Pyrazolone Phosphodiesterase Inhibitors in Experimental Mouse Models of Trypanosoma cruzi.
de Araújo JS; França da Silva C; Batista DDGJ; Nefertiti A; Fiuza LFA; Fonseca-Berzal CR; Bernardino da Silva P; Batista MM; Sijm M; Kalejaiye TD; de Koning HP; Maes L; Sterk GJ; Leurs R; Soeiro MNC
Antimicrob Agents Chemother; 2020 Aug; 64(9):. PubMed ID: 32601163
[TBL] [Abstract][Full Text] [Related]
36. An Aromatic Diamidine That Targets Kinetoplast DNA, Impairs the Cell Cycle in Trypanosoma cruzi, and Diminishes Trypomastigote Release from Infected Mammalian Host Cells.
Girard RM; Crispim M; Stolić I; Damasceno FS; Santos da Silva M; Pral EM; Elias MC; Bajić M; Silber AM
Antimicrob Agents Chemother; 2016 Oct; 60(10):5867-77. PubMed ID: 27431229
[TBL] [Abstract][Full Text] [Related]
37. The trypanocidal activity of amidine compounds does not correlate with their binding affinity to Trypanosoma cruzi kinetoplast DNA.
Daliry A; Pires MQ; Silva CF; Pacheco RS; Munde M; Stephens CE; Kumar A; Ismail MA; Liu Z; Farahat AA; Akay S; Som P; Hu Q; Boykin DW; Wilson WD; De Castro SL; Soeiro MN
Antimicrob Agents Chemother; 2011 Oct; 55(10):4765-73. PubMed ID: 21807972
[TBL] [Abstract][Full Text] [Related]
38. In Vitro Image-Based Assay for Trypanosoma cruzi Intracellular Forms.
Eufrásio AG; Cordeiro AT
Methods Mol Biol; 2020; 2116():773-780. PubMed ID: 32221954
[TBL] [Abstract][Full Text] [Related]
39. Identification of Pyrazolo[3,4-e][1,4]thiazepin based CYP51 inhibitors as potential Chagas disease therapeutic alternative: In vitro and in vivo evaluation, binding mode prediction and SAR exploration.
Ferreira de Almeida Fiuza L; Peres RB; Simões-Silva MR; da Silva PB; Batista DDGJ; da Silva CF; Nefertiti Silva da Gama A; Krishna Reddy TR; Soeiro MNC
Eur J Med Chem; 2018 Apr; 149():257-268. PubMed ID: 29501946
[TBL] [Abstract][Full Text] [Related]
40. Phenyl substitution of furamidine markedly potentiates its anti-parasitic activity against Trypanosoma cruzi and Leishmania amazonensis.
De Souza EM; Lansiaux A; Bailly C; Wilson WD; Hu Q; Boykin DW; Batista MM; Araújo-Jorge TC; Soeiro MN
Biochem Pharmacol; 2004 Aug; 68(4):593-600. PubMed ID: 15276066
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
